Literature DB >> 17113582

Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells.

Alena Vaculová1, Jirina Hofmanová, Karel Soucek, Alois Kozubík.   

Abstract

Epithelial cells can be manipulated to undergo apoptosis depending on the balance between pro-survival and apoptotic signals. We showed that TRAIL-induced apoptosis may be differentially regulated by inhibitors of MEK ERK (U0126) or PI3K/Akt (LY294002) pathway in TRAIL-sensitive (HT-29) and TRAIL-resistant (SW620) human epithelial colon cancer cells. U0126 or LY294002 significantly enhanced TRAIL-induced apoptosis in HT-29 cells, but not in SW620 cells. We report a different regulation of the level of an anti-apoptotic Mcl-1 protein under MEK/ERK or PI3K/Akt pathway inhibition and suggest the mechanisms involved. A special attention was paid to the role of the ERK1/2, Akt, and glycogen synthase kinase 3beta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113582     DOI: 10.1016/j.febslet.2006.11.004

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.

Authors:  Xiaoyun Dai; Jingwen Zhang; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Alan Prem Kumar; Kwang Seok Ahn; Gautam Sethi
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-07

Review 2.  TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.

Authors:  Peter A Holoch; Thomas S Griffith
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

Review 3.  TRAIL gene therapy: from preclinical development to clinical application.

Authors:  Thomas S Griffith; Brittany Stokes; Tamara A Kucaba; James K Earel; Rebecca L VanOosten; Erik L Brincks; Lyse A Norian
Journal:  Curr Gene Ther       Date:  2009-02       Impact factor: 4.391

4.  Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.

Authors:  Henning Schulze-Bergkamen; Roland Ehrenberg; Lothar Hickmann; Binje Vick; Toni Urbanik; Christoph-C Schimanski; Martin-R Berger; Arno Schad; Achim Weber; Steffen Heeger; Peter-R Galle; Markus Moehler
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

5.  Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis.

Authors:  Joseph E Aslan; Huihong You; Danielle M Williamson; Jessica Endig; Robert T Youker; Laurel Thomas; Hongjun Shu; Yuhong Du; Robert L Milewski; Matthew H Brush; Anthony Possemato; Kam Sprott; Haian Fu; Kenneth D Greis; Douglas N Runckel; Arndt Vogel; Gary Thomas
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

Review 6.  Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family.

Authors:  K Azijli; B Weyhenmeyer; G J Peters; S de Jong; F A E Kruyt
Journal:  Cell Death Differ       Date:  2013-04-12       Impact factor: 15.828

7.  Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas.

Authors:  C Holgren; U Dougherty; F Edwin; D Cerasi; I Taylor; A Fichera; L Joseph; M Bissonnette; S Khare
Journal:  Oncogene       Date:  2010-07-26       Impact factor: 9.867

8.  Selective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance.

Authors:  Eftychia Oikonomou; Michal Koc; Vladimira Sourkova; Ladislav Andera; Alexander Pintzas
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

9.  Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.

Authors:  Alois Kozubík; Alena Vaculová; Karel Soucek; Jan Vondrácek; Jaroslav Turánek; Jirina Hofmanová
Journal:  Met Based Drugs       Date:  2008

Review 10.  Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.

Authors:  Jiřina Hofmanová; Nicol Straková; Alena Hyršlová Vaculová; Zuzana Tylichová; Barbora Safaříková; Belma Skender; Alois Kozubík
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.